Amir Patel, MD
Gastroenterology · Sheboygan, WINPI 1265685200
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $111,700 of the $137,034 with a category attached, or 81.5%. 8 manufacturers reported payments, led by AbbVie at 43.1% of the total. 2025 is the largest year on record at $81,772, more than ten times the $503 reported in 2019. Among gastroenterology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $1054.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$59K
- Johnson & Johnson$59K
- E.r. Squibb & Sons, L.L.C.$14K
- Bristol Myers Squibb$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Ardelyx, Inc.$128
- plus $250 from 2 others
Across 21 payments — averaging $9859.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$115K
- Vectivbio AG$92K
What the payments were for
- Consulting fees$4,2003%
- Speaking & faculty fees$111,70082%
- Travel & lodging$15,93712%
- Food & beverage$5,1984%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $59,038 |
| Johnson & Johnson | 42 | $58,905 |
| E.r. Squibb & Sons, L.L.C. | 11 | $14,296 |
| Bristol Myers Squibb | 10 | $3,229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $1,188 |
| Ardelyx, Inc. | 1 | $128 |
| Pfizer | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$137,034 in reported general payments places this provider in the 95th percentile of 285 gastroenterology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 31 | $803,799 |
| Skyrizi On-BodyRisankizumab-Rzaa | 15 | $291,415 |
| InflectraInfliximab-Dyyb | 15 | $81,259 |
| Humira(Cf)Adalimumab | 11 | $76,538 |
| LinzessLinaclotide | 14 | $18,135 |
| Omeprazole | 82 | $1,406 |
| Lactated RingersRinger's Solution,lactated | 12 | $692 |
| Humulin RInsulin Regular, Human | 14 | $642 |
| Famotidine | 22 | $542 |
| Pantoprazole Sodium | 36 | $380 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 26 | $328 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $313 |
| Cefepime Hcl | 43 | $281 |
| Azathioprine | 17 | $235 |
| Ondansetron OdtOndansetron | 41 | $181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $58,905 | $803,79931 claims |
| AbbVieHumira(Cf), Linzess | $59,038 | $94,67325 claims |
| PfizerInflectra | $125 | $81,25915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 285 gastroenterology providers in Wisconsin.
Other gastroenterology in Sheboygan
- Michael BairdSheboygan$4K
- Daniel SteinMilwaukee$227K
- Poonam Beniwal-PatelMilwaukee$108K
- Lilani PereraMequon$95K
- Freddy CalderaMadison$72K
- Matthew PellerMilwaukee$63K
- Susan LepinskiMadison$61K
- Chetan MittalMilwaukee$53K
- Pedro Palacios ArguetaEau Claire$53K
- Patrick SanvansonMilwaukee$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.